About
Leadership
Leadership Team
Our experienced Executive Team works closely with the Board of Directors to develop and agree the company’s strategic direction and engages with our Leadership Team to oversee execution.
The Board of Directors is responsible for the governance of the company and works with the Executive Team to develop and agree strategic direction.
The Scientific Advisory Board and Clinical Advisory Board bring diverse expertise to both the Board and Executive team and are consulted on all directional scientific and clinical decisions.
Kevin Lee, Ph.D., MBA
Chief Executive Officer and Director
Mike Hannay, D.Sc., FRPharmS
Chief Product and Supply Chain Officer
Jim MacDonald-Clink
SVP, Head of Business Development
Alistair Milnes
Chief Operating Officer
Jennifer Perry, Pharm.D.
Chief Strategy Officer and Head of Commercial
Zafar Qadir
Chief Legal Officer and General Counsel
Michael Skynner, Ph.D.
Chief Technology Officer
Eric Westin, M.D.
Chief Medical Officer
Alethia Young
Chief Financial Officer
Board of Directors
Pierre Legault, MBA, CPA
Chairman
Felix J. Baker, Ph.D.
Director
Janice Bourque, MBA
Director
Jose-Carlos Gutierrez-Ramos, Ph.D.
Director
Richard N. Kender, MBA
Director
Kevin Lee, Ph.D., MBA
Chief Executive Officer and Director
Alessandro Riva
M.D.
Stephen Sands, MBA
Director
Sir Greg Winter, FRS
Co-founder and Director
Scientific Advisory Board
Sir Keith Peters
GBE, Sc.D., FRCP, FRS, FMedSci
Garret FitzGerald
M.D., FRS
Jane Grogan
Ph.D.
Caetano Reis e Sousa
DPhil, FRS, FMedSci
Geoffrey Shapiro
M.D., Ph.D.
Charles Swanton
M.D., Ph.D., FRS, FMedSci, FRCP
Clinical Advisory Board
Charles Swanton
M.D., Ph.D., FRS, FMedSci, FRCP
Fabrice André
M.D., Ph.D.
Howard A. "Skip" Burris, III
M.D.
Toni K. Choueiri
M.D.
Markus Eckstein
M.D.
Niklas Klümper
M.D.
Sherene Loi
MBBS (Hons), Ph.D., FRACP, FAHMS
Solange Peters
M.D., Ph.D.